Basilea Pharmaceutica AG (SWX:BSLN)
44.10
+0.45 (1.03%)
May 16, 2025, 10:32 AM CET
Basilea Pharmaceutica AG Market Cap
Basilea Pharmaceutica AG has a market cap or net worth of 535.50 million as of May 15, 2025. Its market cap has increased by 10.70% in one year.
Market Cap
535.50M
Enterprise Value
526.46M
Revenue
208.54M
Ranking
n/a
PE Ratio
7.49
Stock Price
44.10
Market Cap Chart
Since March 25, 2004, Basilea Pharmaceutica AG's market cap has increased from 533.29M to 535.50M, an increase of 0.41%. That is a compound annual growth rate of 0.02%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Roche Holding AG | 207.55B |
Novartis AG | 176.53B |
Lonza Group AG | 40.53B |
Alcon | 39.17B |
Galderma Group AG | 23.27B |
Straumann Holding AG | 18.20B |
Sandoz Group AG | 16.29B |
Sonova Holding AG | 16.04B |